IQVIA Holdings Inc. (IQV) has had an impressive run over the past three months. The stock has gained 9.3%, outperforming the 3.9% rise of the industry it belongs to and the Zacks S&P 500 composite's 2% uptick. IQV has an expected long-term (three to five years) EPS growth rate of 10.4%. The company's earnings for 2024 and 2025 are expected to grow 9.6% and 10.6%, respectively. IQV's Global Reach, Market Leadership in Healthcare Analytics IQVIA operates in over 100 countries, giving it a vast global footprin ...